Literature DB >> 9269058

Associations of prevaccination antibody levels with adverse reactions to pneumococcal and influenza vaccines administered simultaneously in the elderly.

U Sankilampi1, P O Honkanen, R Pyhälä, M Leinonen.   

Abstract

The association of prevaccination antibodies with the adverse reactions seen after vaccination was studied in 85 elderly subjects (65-90 years) vaccinated simultaneously with pneumococcal and influenza vaccines. The subjects with a temperature rise (9% of vaccinees) had significantly higher prevaccination antibody levels to pneumococcal capsular polysaccharides (PPSs) than those without a temperature rise; no difference was seen in their haemagglutination inhibiting (HI) influenza virus antibody levels. Pain in the left arm (the pneumococcal vaccine injection site) occurred in 45% of the subjects and was likewise associated with elevated PPS antibody levels. Pain at the site of influenza vaccine injection (the right arm) seen in 33% of the vaccinees was significantly more common among those who had previously received influenza vaccine, but was not associated with elevated HI antibody levels. In conclusion, prevaccination pneumococcal but not influenza antibodies were associated with both systemic and local reactions following vaccination.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9269058     DOI: 10.1016/s0264-410x(96)00317-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

Review 1.  Pneumococcal disease in the elderly: what is preventing vaccine efficacy?

Authors:  J B Rubins; E N Janoff
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 2.  Pneumococcal vaccination and revaccination of older adults.

Authors:  Andrew S Artz; William B Ershler; Dan L Longo
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

3.  Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults.

Authors:  Masanari Shiramoto; Ryuzo Hanada; Christine Juergens; Yasuko Shoji; Mizuki Yoshida; Barry Ballan; David Cooper; William C Gruber; Daniel A Scott; Beate Schmoele-Thoma
Journal:  Hum Vaccin Immunother       Date:  2015-07-15       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.